Premium
Polymicrobial bacterial or fungal infections: incidence, spectrum of infection, risk factors, and clinical outcomes from a large hematopoietic stem cell transplant center
Author(s) -
Trifilio S.,
Zhou Z.,
Fong J.L.,
Zomas A.,
Liu D.,
Zhao C.,
Zhang J.,
Mehta J.
Publication year - 2015
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12363
Subject(s) - medicine , incidence (geometry) , hematopoietic stem cell transplantation , stem cell , risk factor , immunology , hematopoietic stem cell , pathogenic organism , intensive care medicine , haematopoiesis , microbiology and biotechnology , transplantation , biology , physics , optics , genetics
Background Infections cause significant morbidity and mortality for patients who undergo hematopoietic stem cell transplantation ( HSCT ). Cancer patients who develop polymicrobial infection ( PI ) are at increased risk for poor clinical outcomes, yet very limited data have been published within the HSCT setting. Methods An observational study of 901 stem cell transplant recipients was conducted at Northwestern Memorial Hospital to identify the incidence, risk factors and outcomes for HSCT recipients who develop infection(s) with multiple bacterial or fungal organisms. Results Among 901 HSCT recipients reviewed (675 autografts and 226 allografts), 237 patients (27%) had microbiologically documented microorganisms isolated, including 179 patients (76%) with monomicrobial infection and 59 patients (24%) with multiple microorganisms, of which 34 (14%) were classified as PI , and 25 (10%) as multiple distinct episodes of infection. Conclusion The results show co‐infection with multiple organisms during HSCT is relatively rare; however, these patients are at an increased risk for the development of acute graft‐versus‐host disease, delayed engraftment, and overall mortality.